Siegfried Holding AG (XSWX:SFZN) EPS without NRI: CHF3.69 (TTM As of Dec. 2025)


XSWX:SFZN Siegfried Holding AG XSWX:SFZN
93 GF Score
Price CHF71.80
GF Value CHF92.08
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Siegfried Holding AG EPS without NRI?

Siegfried Holding AG XSWX:SFZN -0.49% 93 EPS without NRI is CHF3.69 as of Dec. 2025. GuruFocus rates XSWX:SFZN with a GF Score™ of 93/100 and a GF Value™ of CHF92.08 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 786 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 53.31% on this metric.

Siegfried Holding AG's earnings per share without non-recurring items for the six months ended in Dec. 2025 was CHF2.19. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was CHF3.69.

During the past 12 months, Siegfried Holding AG's average earnings per share (NRI) Growth Rate was 0.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 7.60% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 16.80% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 18.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Siegfried Holding AG's EPS without NRI or its related term are showing as below:

XSWX:SFZN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -78.5   Med: 18.6   Max: 446.8
Current: 7.6

During the past 13 years, Siegfried Holding AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 446.80% per year. The lowest was -78.50% per year. And the median was 18.60% per year.

XSWX:SFZN's 3-Year EPS without NRI Growth Rate is ranked worse than
53.31% of 786 companies
in the Drug Manufacturers industry
Industry Median: 9.65 vs XSWX:SFZN: 7.60

Siegfried Holding AG's EPS (Diluted) for the six months ended in Dec. 2025 was CHF2.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF3.84.

Siegfried Holding AG's EPS (Basic) for the six months ended in Dec. 2025 was CHF2.35. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF3.85.


Siegfried Holding AG  (XSWX:SFZN) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Siegfried Holding AG EPS without NRI Related Terms


Siegfried Holding AG EPS without NRI Historical Data

* Premium members only.

The historical data trend for Siegfried Holding AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Siegfried Holding AG EPS without NRI Chart

Siegfried Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.20 2.96 2.98 3.66 3.69

Siegfried Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 1.67 1.99 1.50 2.19

XSWX:SFZN vs ZTS, UTHR, VTRS: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's PE Ratio without NRI falls into.


XSWX:SFZN
93GF Score
Siegfried Holding AG XSWX:SFZN
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siegfried Holding AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF3.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of CHF3.69 mean?
Siegfried Holding AG (XSWX:SFZN) has a EPS without NRI of CHF3.69 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Siegfried Holding AG and its competitors. According to the industry distribution chart, Siegfried Holding AG ranks #419 out of 786 companies in the Drug Manufacturers industry, placing it in the top 53.3%.
Is Siegfried Holding AG's EPS without NRI too high?
Siegfried Holding AG's current EPS without NRI is CHF3.69. Based on the distribution chart, Siegfried Holding AG ranks #419 out of 786 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Siegfried Holding AG has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #419 out of 786 companies for EPS without NRI. This places Siegfried Holding AG in the lower half of its industry. The industry median EPS without NRI is 9.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.65, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current EPS without NRI is CHF3.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF92.08, compared to a current price of CHF71.80 — trading 22% below its estimated fair value. The current EPS without NRI is CHF3.69. Siegfried Holding AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current EPS without NRI is CHF3.69 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?

Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued. The current stock price of CHF71.80 is trading 22% below its estimated GF Value™ of CHF92.08. GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:SFZN:

  • EPS without NRI: CHF3.69
  • GF Value™: CHF92.08 vs. price of CHF71.80 (22% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siegfried Holding AG Business Description

Address Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
93GF Score

Get the complete analysis for XSWX:SFZN

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF71.80
Price
CHF92.08
GF Value